These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28392221)

  • 21. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
    Orouji E; Federico A; Larribère L; Novak D; Lipka DB; Assenov Y; Sachindra S; Hüser L; Granados K; Gebhardt C; Plass C; Umansky V; Utikal J
    Int J Cancer; 2019 Dec; 145(12):3462-3477. PubMed ID: 31131878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.
    Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N
    Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling?
    Yilmazer A; de Lázaro I; Taheri H
    Cancer Lett; 2015 Dec; 369(1):1-8. PubMed ID: 26276716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity.
    Nishizawa M; Chonabayashi K; Nomura M; Tanaka A; Nakamura M; Inagaki A; Nishikawa M; Takei I; Oishi A; Tanabe K; Ohnuki M; Yokota H; Koyanagi-Aoi M; Okita K; Watanabe A; Takaori-Kondo A; Yamanaka S; Yoshida Y
    Cell Stem Cell; 2016 Sep; 19(3):341-54. PubMed ID: 27476965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reprogramming of retinoblastoma cancer cells into cancer stem cells.
    Yue F; Hirashima K; Tomotsune D; Takizawa-Shirasawa S; Yokoyama T; Sasaki K
    Biochem Biophys Res Commun; 2017 Jan; 482(4):549-555. PubMed ID: 27856246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of miRNA-212/132 improves the reprogramming of fibroblasts into induced pluripotent stem cells by de-repressing important epigenetic remodelling factors.
    Pfaff N; Liebhaber S; Möbus S; Beh-Pajooh A; Fiedler J; Pfanne A; Schambach A; Thum T; Cantz T; Moritz T
    Stem Cell Res; 2017 Apr; 20():70-75. PubMed ID: 28314201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
    Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
    Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
    Greder LV; Post J; Dutton JR
    Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing mammary differentiation by overcoming lineage-specific epigenetic modification and signature gene expression of fibroblast-derived iPSCs.
    Li Y; Hong N; Zhang A; Chen W; Wang RH; Xu XL; Deng CX
    Cell Death Dis; 2014 Dec; 5(12):e1550. PubMed ID: 25476898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential gene expression and epigenetic memory of induced pluripotent stem cells derived from mouse pancreas.
    Nukaya D; Minami K; Hoshikawa R; Yokoi N; Seino S
    Genes Cells; 2015 May; 20(5):367-81. PubMed ID: 25727848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
    Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
    PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Derivation of LIF-independent mouse iPS cells with modified Oct4.
    Hirai H; Firpo M; Kikyo N
    Stem Cell Res; 2015 Sep; 15(2):384-6. PubMed ID: 26318720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative Routes to Induced Pluripotent Stem Cells Revealed by Reprogramming of the Neural Lineage.
    Jackson SA; Olufs ZP; Tran KA; Zaidan NZ; Sridharan R
    Stem Cell Reports; 2016 Mar; 6(3):302-11. PubMed ID: 26905202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.
    Pomeroy JE; Hough SR; Davidson KC; Quaas AM; Rees JA; Pera MF
    Stem Cells Transl Med; 2016 Jul; 5(7):870-82. PubMed ID: 27160704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear reprogramming with a non-integrating human RNA virus.
    Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
    Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour resistance in induced pluripotent stem cells derived from naked mole-rats.
    Miyawaki S; Kawamura Y; Oiwa Y; Shimizu A; Hachiya T; Bono H; Koya I; Okada Y; Kimura T; Tsuchiya Y; Suzuki S; Onishi N; Kuzumaki N; Matsuzaki Y; Narita M; Ikeda E; Okanoya K; Seino K; Saya H; Okano H; Miura K
    Nat Commun; 2016 May; 7():11471. PubMed ID: 27161380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells.
    Knappe N; Novak D; Weina K; Bernhardt M; Reith M; Larribere L; Hölzel M; Tüting T; Gebhardt C; Umansky V; Utikal J
    Stem Cells; 2016 Apr; 34(4):832-46. PubMed ID: 26753613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
    Quintana-Bustamante O; Segovia JC
    Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.